COVID-19, the Female Immune Advantage, and Cardiovascular Impact
Mayo Clin Proc
.
2021 Mar;96(3):820-821.
doi: 10.1016/j.mayocp.2020.12.021.
Epub 2020 Dec 29.
Authors
Felice L Gersh
1
,
James H O'Keefe
2
,
Brandon M Henry
3
Affiliations
1
University of Arizona School of Medicine, Tucson.
2
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City.
3
Cincinnati Children's Hospital, The Heart Institute, CICU, OH.
PMID:
33673933
PMCID:
PMC7832658
DOI:
10.1016/j.mayocp.2020.12.021
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Cardiovascular Diseases* / epidemiology
Cardiovascular System*
Female
Heart
Humans
SARS-CoV-2